Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIABETES.54.12.3418PMID 16306357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of acute-phase response proteins in retinal Müller cells in diabetes.

  2005cited by this paper
• Inhibition of p90 Ribosomal S6 Kinase-mediated CCAAT/Enhancer-binding Protein β Activation and Cyclooxygenase-2 Expression by Salicylate*

  2005cited by this paper
• Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.

  2004influential reference
• Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

  2004cited by this paper
• Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.

  2004cited by this paper
• Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.

  2004cited by this paper
• Cerebral lesions in rats with streptozotocin-induced diabetes

  2004cited by this paper
• Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-κB

  2004cited by this paper
• Molecular determinants of retinal ganglion cell development, survival, and regeneration.

  2003cited by this paper
• A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one.

  2003cited by this paper
• Optical bioimaging: from living tissue to a single molecule: imaging and functional analysis of blood flow in organic microcirculation.

  2003cited by this paper
• A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.

  2003influential reference
• Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.

  2002cited by this paper
• Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.

  2002cited by this paper
• Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression

  2002cited by this paper
• CCAAT/enhancer-binding proteins: structure, function and regulation.

  2002cited by this paper
• Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

  2001cited by this paper
• Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

  2001cited by this paper
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001cited by this paper
• IGF-I mRNA and signaling in the diabetic retina.

  2001cited by this paper
• Cyclooxygenase‐independent actions of cyclooxygenase inhibitors

  2001cited by this paper
• Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.

  2001cited by this paper
• Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

  2000cited by this paper
• Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment.

  1999cited by this paper
• Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

  1999cited by this paper
• Microaneurysms in the development of diabetic retinopathy (UKPDS 42)

  1999cited by this paper
• Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

  1999cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

  1998cited by this paper
• Renal CCAAT/Enhancer-Binding Proteins in ExperimentalDiabetes mellitu s

  1998cited by this paper
• Müller cell changes in human diabetic retinopathy.

  1998cited by this paper
• Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.

  1998influential reference
• Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

  1998cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

  1998cited by this paper
• Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

  1997cited by this paper
• Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel

  1997cited by this paper
• Aspirin protects endothelial cells from oxidative stress – possible synergism with vitamin E

  1997cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

  1996cited by this paper
• Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

  1996cited by this paper
• Assessment of blood-retinal barrier integrity.

  1995cited by this paper
• Retinal microaneurysm counts and 10-year progression of diabetic retinopathy.

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Molecular profile of reactive astrocytes—Implications for their role in neurologic disease

  1993cited by this paper
• CLINICAL-STUDY OF TICLOPIDINE IN DIABETIC-RETINOPATHY.

  1992cited by this paper
• Clinical study of ticlopidine in diabetic retinopathy. Belgian Ticlopidine Retinopathy Study Group (BTRS).

  1992cited by this paper
• Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group.

  1990cited by this paper
• Effect of Aspirin Alone and Aspirin Plus Dipyridamole in Early Diabetic Retinopathy: A Multicenter Randomized Controlled Clinical Trial

  1989cited by this paper
• Goodman & Gilman's The Pharmacological Basis of Therapeutics

  1985cited by this paper
• The BB-rat--an authentic model of human diabetic retinopathy.

  1985cited by this paper
• Arachidonic acid metabolism by retinas of rats with streptozotocin-induced diabetes.

  1984cited by this paper
• Platelet Aggregation and Coagulation in the Pathogenesis of Diabetic Retinopathy in Rats

  1981cited by this paper
• Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects.

  1980cited by this paper
• Patterns of ischemia in diabetic retinopathy.

  1976cited by this paper
• The Pharmacological Basis of Therapeutics

  1941cited by this paper

• Old Target with New Vision: In Search of New Therapeutics for Diabetic Retinopathy by Selective Modulation of Aldose Reductase

  2026cites this paper
• INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study

  2025influential citation
• Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review

  2024cites this paper
• ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.

  2024cites this paper
• IL-1\(\beta\) Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1\(\beta\) Autostimulation

  2023cites this paper
• ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration

  2023cites this paper
• Endothelial YAP Mediates Hyperglycemia-Induced Platelet Hyperactivity and Arterial Thrombosis

  2023cites this paper
• Local Inflammatory Biomarkers and Potential Inflammation-Targeting Therapies in Diabetic Retinopathy

  2021cites this paper
• Diabetes mellitus and muscle infarction

  2020cites this paper
• Extracellular Vesicles and MicroRNA: Putative Role in Diagnosis and Treatment of Diabetic Retinopathy

  2020cites this paper
• Current Strategies and Future Perspective for the Effective Treatment of Diabetic Retinopathy

  2020cites this paper
• Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study

  2019cites this paper
• Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.

  2019cites this paper
• Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors.

  2019cites this paper
• Recent advances in cognitive gene diabetic database

  2019cites this paper
• Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.

  2019cites this paper
• Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis.

  2019cites this paper
• Specialized pro-resolving mediators in diabetes: novel therapeutic strategies.

  2019cites this paper
• Role of Inflammation in Diabetic Retinopathy

  2018cites this paper
• Intravitreal Administration of Lysine-Acetylsalicylate Could be an Effective Approach to Preserve Retinal Vessels and to Inhibit Leukostasis in Experimental Diabetic Retinopathy

  2018cites this paper
• Diagnosis and treatment of diabetic retinopathy — historical overview

  2017cites this paper
• The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.

  2017cites this paper
• Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?

  2017cites this paper
• PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

  2016cites this paper
• Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial.

  2016cites this paper
• Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades

  2016cites this paper
• Effect of fenofibrate and aspirin on acute central serous chorioretinopathy

  2016cites this paper
• Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

  2016cites this paper
• PGE 2 , Kidney Disease , and Cardiovascular Risk : Beyond Hypertension and Diabetes

  2016cites this paper
• Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.

  2015cites this paper
• Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10.

  2015cites this paper
• GENISTEIN ALLEVIATES HIGH GLUCOSE INDUCED TOXICITY AND ANGIOGENESIS IN CULTURED HUMAN RPE CELLS

  2015cites this paper
• Diabetic muscle infarction: a systematic review

  2015cites this paper
• Novel drugs and their targets in the potential treatment of diabetic retinopathy

  2013cites this paper
• IL-1β Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1β Autostimulation

  2012cites this paper
• IL-1\(\beta\) Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1\(\beta\) Autostimulation available. Please share how this access benefits you. Your story matters

  2012cites this paper
• IL-1 b Is Upregulated in the Diabetic Retina and Retinal Vessels : Cell-Specific Effect of High Glucose and IL-1 b Autostimulation

  2012cites this paper
• Capillary Degeneration in Diabetic Retinopathy

  2012cites this paper
• Effect of Some Anti-Inflammatory Drugs with and Without Antioxidant on Some Inflammatory Mediators in Diabetic Male Albino Rats

  2011cites this paper
• Anti-inflammatory therapy for diabetic retinopathy.

  2011cites this paper
• Effect of systemic medications on onset and progression of diabetic retinopathy

  2010cites this paper
• New Insights into Hyperglycemia-induced Molecular Changes in Microvascular Cells

  2010cites this paper
• Chapter 65 – Vascular damage in diabetic retinopathy

  2010cites this paper
• The TGF-β pathway is a common target of drugs that prevent experimental diabetic retinopathy Running title: Drug targets in diabetic retinopathy

  2009cites this paper
• Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.

  2009cites this paper
• The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy

  2009influential citation
• Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy.

  2009cites this paper
• The Role of Inflammation in the Pathophysiology of Diabetic Retinopathy

  2008cites this paper
• Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

  2008cites this paper
• Genistein inhibits aldose reductase activity and high glucose-induced TGF-beta2 expression in human lens epithelial cells.

  2008cites this paper
• Immunological mechanisms in the pathogenesis of diabetic retinopathy

  2008cites this paper
• Diabetic complications and dysregulated innate immunity.

  2008cites this paper
• University of Warwick institutional repository: http://go

  2008cites this paper
• The Polyol Pathway and Diabetic Retinopathy

  2008cites this paper
• In vivo Models of Diabetic Retinopathy

  2008cites this paper
• Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology

  2007cites this paper
• Implication of Proinflammatory Reactions in Pathogenesis of Diabetic Microvascular Complications [Emerging Theories of Host Defense. The 10th Meeting Hirosaki International Forum of Medical Science. Communication Center Hirosaki University School of Medicine. Hirosaki on November 21-22, 2006]

  2007cites this paper
• Ticlopidine prevents the formation but delays the healing of ethanol-induced gastric lesions in the rat.

  2007cites this paper
• Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

  2007cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas.

  2007cites this paper
• Cellular Signaling and Potential New Treatment Targets in Diabetic Retinopathy

  2007cites this paper
• Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy

  2007cites this paper
• Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy

  2007influential citation
• The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient

  2007cites this paper
• Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes.

  2007cites this paper
• Current literature in diabetes

  2006cites this paper
• Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats

  2006cites this paper
• Traitement médical de la rétinopathie diabétique

  2006cites this paper
• A Selective Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses Early Retinal Abnormalities in Experimental Diabetic Retinopathy

  2006cites this paper
• Mechanisms and strategies for prevention in diabetic retinopathy

  2006cites this paper